Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Sono Group N.V. (SSM) Form 424B5 — Sep 2, 2026

$SSMForm 424B5Filed Sep 2, 2026, 4:05 PM ET0001171843-26-005852Original filing

Sono Group N.V. (Nasdaq: SSM) is selling 283,500 ordinary shares at $2.67 per share in a registered direct offering to accredited investors and qualified institutional buyers, for gross proceeds of $756,945 and estimated net proceeds of about $556,945 after expenses. There is no underwriter or placement agent, and delivery is expected on or about September 2, 2026. The offering is sized at roughly 19.9% of the company's 1,424,834 shares outstanding, just below the Nasdaq 20% shareholder-approval threshold, and new investors face immediate dilution of $3.98 per share against a net tangible book deficit of $(1.96) per share as of June 30, 2026.

Key figures

Cash Position
166000
Gross Proceeds
756945
Offering Price
2.67
Shares Offered
283500
Net Proceeds
556945
Fy2025 Net Income
€4.0 million (driven by fair value gains on convertible debentures)
Cash Position As Of
March 31, 2026
Offering Expenses
200000
Reverse Split Ratio
1-for-75 (effective January 6, 2025)
Fy2025 Operating Loss
€7.7 million
Subsidiary Sale Price
€1.00 (Sono Motors GmbH, May 4, 2026)
Dilution Per New Investor
$3.98 per share
Call Option Aggregate Cost
approximately $21.0 million
Call Option Preferred Shares
700
Preferred Shares Outstanding
1401
Accumulated Deficit Dec31 2025
approximately $317.4 million
Shares Outstanding Pre Offering
1424834
Prior Debt Converted To Preferred
approximately $42.1 million
Shares Outstanding After Offering
1708334
Offering Percent Of Shares Outstanding
19.9%
Net Tangible Book Value Per Share Jun30 2026
$(1.96)
Ordinary Shares Issuable On Preferred Conversion
42030000

Price after filing

1 day: 0.0%7 days: -52.0%30 days: -54.0%

Close on the filing date to close N calendar days later (from $4.80). Historical, not a forecast.

AI analysis

Red flags10 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.